VAP-PRO-C6. Effectiveness and Tolerability of Venoactive Drugs in Combination Therapy in Patients With CVD (CEAP C6)
N/A
Completed
NCT04757766
| Condition | Chronic Venous Insufficiency |
|---|
| Phase | N/A |
|---|
| Sponsor | Servier Russia |
|---|
| Status | Completed |
|---|
| Enrollment | 350 participants |
|---|
| Interventions | in daily everyday routine practice |
|---|
| Start date | Mar 1, 2021 |
|---|
| Completion date | May 31, 2022 |
|---|
| Results posted | Sep 19, 2024 |
|---|
Summary
The VAP-PRO-C6 is a Russian multicenter observational program to be implemented at the routine visits and assessments. The program will include patients with chronic venous disease of CEAP classes C6. This program is planned to be carried out in Russia in 2021-2022.
Eeffectiveness of Systemic Pharmacotherapy as a Part of Combination Therapy
6 months · Participants
| Patients With Venous Ulcers (CEAP Classes C6) Treated in Daily Clinical Practice | 243 Participants |
|---|
Eeffectiveness of Systemic Pharmacotherapy
6 months · Participants
| Patients With Venous Ulcers (CEAP Classes C6) Treated in Daily Clinical Practice | 247 Participants |
|---|
Open in BENITIONS
View on ClinicalTrials.gov
All trials
This page summarises publicly available data from ClinicalTrials.gov. It is not medical advice and not investment advice. Always consult a qualified healthcare professional.